Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 157

1.

Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression.

Wright PW, Li H, Huehn A, O'Connor GM, Cooley S, Miller JS, Anderson SK.

Genes Immun. 2014 Jul 3. doi: 10.1038/gene.2014.34. [Epub ahead of print]

PMID:
24989671
[PubMed - as supplied by publisher]
2.

Transcriptional regulation of Munc13-4 expression in cytotoxic lymphocytes is disrupted by an intronic mutation associated with a primary immunodeficiency.

Cichocki F, Schlums H, Li H, Stache V, Holmes T, Lenvik TR, Chiang SC, Miller JS, Meeths M, Anderson SK, Bryceson YT.

J Exp Med. 2014 Jun 2;211(6):1079-91. doi: 10.1084/jem.20131131. Epub 2014 May 19.

PMID:
24842371
[PubMed - in process]
3.

Functional NK cell repertoires are maintained through IL-2Rα and Fas ligand.

Felices M, Lenvik TR, Ankarlo DE, Foley B, Curtsinger J, Luo X, Blazar BR, Anderson SK, Miller JS.

J Immunol. 2014 Apr 15;192(8):3889-97. doi: 10.4049/jimmunol.1302601. Epub 2014 Mar 14.

PMID:
24634493
[PubMed - indexed for MEDLINE]
4.

Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.

O'Connor GM, Vivian JP, Widjaja JM, Bridgeman JS, Gostick E, Lafont BA, Anderson SK, Price DA, Brooks AG, Rossjohn J, McVicar DW.

J Immunol. 2014 Mar 15;192(6):2875-84. doi: 10.4049/jimmunol.1303142. Epub 2014 Feb 21.

PMID:
24563253
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P, Carpenter J, Chang-Claude J, Martin NG, Montgomery GW, Kristensen V, Anton-Culver H, Goodfellow P, Tapper WJ, Rafiq S, Gerty SM, Durcan L, Konstantopoulou I, Fostira F, Vratimos A, Apostolou P, Konstanta I, Kotoula V, Lakis S, Dimopoulos MA, Skarlos D, Pectasides D, Fountzilas G, Beckmann MW, Hein A, Ruebner M, Ekici AB, Hartmann A, Schulz-Wendtland R, Renner SP, Janni W, Rack B, Scholz C, Neugebauer J, Andergassen U, Lux MP, Haeberle L, Clarke C, Pathmanathan N, Rudolph A, Flesch-Janys D, Nickels S, Olson JE, Ingle JN, Olswold C, Slettedahl S, Eckel-Passow JE, Anderson SK, Visscher DW, Cafourek VL, Sicotte H, Prodduturi N, Weiderpass E, Bernstein L, Ziogas A, Ivanovich J, Giles GG, Baglietto L, Southey M, Kosma VM, Fischer HP; GENICA Network, Reed MW, Cross SS, Deming-Halverson S, Shrubsole M, Cai Q, Shu XO, Daly M, Weaver J, Ross E, Klemp J, Sharma P, Torres D, Rüdiger T, Wölfing H, Ulmer HU, Försti A, Khoury T, Kumar S, Pilarski R, Shapiro CL, Greco D, Heikkilä P, Aittomäki K, Blomqvist C, Irwanto A, Liu J, Pankratz VS, Wang X, Severi G, Mannermaa A, Easton D, Hall P, Brauch H, Cox A, Zheng W, Godwin AK, Hamann U, Ambrosone C, Toland AE, Nevanlinna H, Vachon CM, Couch FJ.

Carcinogenesis. 2014 May;35(5):1012-9. doi: 10.1093/carcin/bgt404. Epub 2013 Dec 9.

PMID:
24325915
[PubMed - indexed for MEDLINE]
6.

An integrated model of the transcriptome of HER2-positive breast cancer.

Kalari KR, Necela BM, Tang X, Thompson KJ, Lau M, Eckel-Passow JE, Kachergus JM, Anderson SK, Sun Z, Baheti S, Carr JM, Baker TR, Barman P, Radisky DC, Joseph RW, McLaughlin SA, Chai HS, Camille S, Rossell D, Asmann YW, Thompson EA, Perez EA.

PLoS One. 2013 Nov 1;8(11):e79298. doi: 10.1371/journal.pone.0079298. eCollection 2013.

PMID:
24223926
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Differential expression of the Ly49G(B6), but not the Ly49G(BALB), receptor isoform during natural killer cell reconstitution after hematopoietic stem cell transplantation.

Barao I, Wright PW, Sungur CM, Anderson SK, Redelman D, Murphy WJ.

Biol Blood Marrow Transplant. 2013 Oct;19(10):1446-52. doi: 10.1016/j.bbmt.2013.07.021. Epub 2013 Jul 31.

PMID:
23911940
[PubMed - indexed for MEDLINE]
8.

Identification of a KIR antisense lncRNA expressed by progenitor cells.

Wright PW, Huehn A, Cichocki F, Li H, Sharma N, Dang H, Lenvik TR, Woll P, Kaufman D, Miller JS, Anderson SK.

Genes Immun. 2013 Oct;14(7):427-33. doi: 10.1038/gene.2013.36. Epub 2013 Jul 18.

PMID:
23863987
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Phase II study of bevacizumab in combination with sorafenib in recurrent glioblastoma (N0776): a north central cancer treatment group trial.

Galanis E, Anderson SK, Lafky JM, Uhm JH, Giannini C, Kumar SK, Kimlinger TK, Northfelt DW, Flynn PJ, Jaeckle KA, Kaufmann TJ, Buckner JC.

Clin Cancer Res. 2013 Sep 1;19(17):4816-23. doi: 10.1158/1078-0432.CCR-13-0708. Epub 2013 Jul 5.

PMID:
23833308
[PubMed - indexed for MEDLINE]
10.

Contrasting effects of anti-Ly49A due to MHC class I cis binding on NK cell-mediated allogeneic bone marrow cell resistance.

Alvarez M, Sungur CM, Ames E, Anderson SK, Pomeroy C, Murphy WJ.

J Immunol. 2013 Jul 15;191(2):688-98. doi: 10.4049/jimmunol.1300202. Epub 2013 Jun 10.

PMID:
23752612
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-γ production by repressing β-catenin activation in dendritic cells.

Orr SJ, Burg AR, Chan T, Quigley L, Jones GW, Ford JW, Hodge D, Razzook C, Sarhan J, Jones YL, Whittaker GC, Boelte KC, Lyakh L, Cardone M, O'Connor GM, Tan C, Li H, Anderson SK, Jones SA, Zhang W, Taylor PR, Trinchieri G, McVicar DW.

PLoS Pathog. 2013 May;9(5):e1003357. doi: 10.1371/journal.ppat.1003357. Epub 2013 May 9.

PMID:
23675302
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.

Cen L, Carlson BL, Pokorny JL, Mladek AC, Grogan PT, Schroeder MA, Decker PA, Anderson SK, Giannini C, Wu W, Ballman KV, Kitange GJ, Sarkaria JN.

Neuro Oncol. 2013 Jun;15(6):735-46. doi: 10.1093/neuonc/not010. Epub 2013 Mar 10.

PMID:
23479134
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Epigenetic regulation of NK cell differentiation and effector functions.

Cichocki F, Miller JS, Anderson SK, Bryceson YT.

Front Immunol. 2013 Feb 28;4:55. doi: 10.3389/fimmu.2013.00055. eCollection 2013.

PMID:
23450696
[PubMed]
Free PMC Article
14.

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples.

Mahoney DW, Therneau TM, Anderson SK, Jen J, Kocher JP, Reinholz MM, Perez EA, Eckel-Passow JE.

BMC Res Notes. 2013 Jan 30;6:33. doi: 10.1186/1756-0500-6-33.

PMID:
23360712
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Mouse Nkrp1-Clr gene cluster sequence and expression analyses reveal conservation of tissue-specific MHC-independent immunosurveillance.

Zhang Q, Rahim MM, Allan DS, Tu MM, Belanger S, Abou-Samra E, Ma J, Sekhon HS, Fairhead T, Zein HS, Carlyle JR, Anderson SK, Makrigiannis AP.

PLoS One. 2012;7(12):e50561. doi: 10.1371/journal.pone.0050561. Epub 2012 Dec 4.

PMID:
23226525
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells.

Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren HG, Malmberg KJ.

Blood. 2012 Oct 25;120(17):3455-65. doi: 10.1182/blood-2012-03-416867. Epub 2012 Sep 11.

PMID:
22968455
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Promoter variants in the MSMB gene associated with prostate cancer regulate MSMB/NCOA4 fusion transcripts.

Lou H, Li H, Yeager M, Im K, Gold B, Schneider TD, Fraumeni JF Jr, Chanock SJ, Anderson SK, Dean M.

Hum Genet. 2012 Sep;131(9):1453-66. doi: 10.1007/s00439-012-1182-2. Epub 2012 Jun 4.

PMID:
22661295
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Undergraduate physical activity and depressive symptoms: a national study.

Elliot CA, Kennedy C, Morgan G, Anderson SK, Morris D.

Am J Health Behav. 2012 Mar;36(2):230-41. doi: 10.5993/AJHB.36.2.8.

PMID:
22370260
[PubMed - indexed for MEDLINE]
19.

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study.

Friday BB, Anderson SK, Buckner J, Yu C, Giannini C, Geoffroy F, Schwerkoske J, Mazurczak M, Gross H, Pajon E, Jaeckle K, Galanis E.

Neuro Oncol. 2012 Feb;14(2):215-21. doi: 10.1093/neuonc/nor198. Epub 2011 Nov 16.

PMID:
22090453
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mouse Ly49G2+ NK cells dominate early responses during both immune reconstitution and activation independently of MHC.

Barao I, Alvarez M, Ames E, Orr MT, Stefanski HE, Blazar BR, Lanier LL, Anderson SK, Redelman D, Murphy WJ.

Blood. 2011 Jun 30;117(26):7032-41. doi: 10.1182/blood-2010-11-316653. Epub 2011 Apr 15.

PMID:
21498673
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk